UMR CNRS 5558 Laboratoire de Biométrie et Biologie Évolutive

article :
Bachy E, Bernaud J, Roy P, Rigal D, Nicolini F-E (2011)
Quantitative and functional analyses of CD4+CD25+FoxP3+ regulatory T cells in chronic phase chronic myeloid leukaemia patients at diagnosis and on imatinib mesylate, British Journal of Haematology, vol. 153 pp.129-143

Jézéquel P, Campion L, Spyratos F, Loussouam D, Campone M, Guérin-charbonnel C, Joalland M P, André J, Descotes F, Grenot C, Roy P, Carlioz A, Martin P M, Chassevent A, Jourdan M-L, Ricolleau G (2011)
Validation of tumour-associated macrophage ferritin light chain as a prognostic biomarker in node-negative breast cancer tumours: a multicentric 2004 national PHRC study, International journal of cancer, vol. pp.1-12

Roy P, Truntzer C, Maucort-Boulch D, Jouve T, Molinari N (2011)
Protein mass spectra data analysis for clinical biomarker discovery: a global review, Briefings in Bioinformatics, vol. 12 pp.176-186

Cornu C, Remontet L, Noel-Baron F, Nicolas A, Feugier-Favier N, Roy P, Claustrat B, Saadatian-Elahi M, Kassaï B (2010)
A dietary supplement to improve the quality of sleep: a randomized placebo controlled trial, BMC Complementary and alternative medicine, vol. 10(29) pp.1-32

Raverot G, Wierinckx A, Dantony E, Auger C, Chapas G, Villeneuve L, Brue T, Figarella-Branger D, Roy P, Jouanneau E, Jan M, Lachuer J, Trouillas P (2010)
Prognostic Factors in Prolactin Pituitary Tumors: Clinical Histological and Molecular Data from a Series of 94 Patients with a Long Postoperative Follow-Up, Journal of Clinical Endocrinology and Metabolism, vol. 95(4) pp.1708-1716

Le Scodan R, Mornex F, Girard N, Mercier C, Valette P-J, Ychou M, BIbeau F, Roy P, Scoazec J-Y, Partensky C (2009)
Preoperative chemoradiation in potentially resectable pancreatic adenocarcinoma: feasibility treatment effect evaluation and prognostic factors analysis of the SFRO-FFCD 9704 trial and literature review, Annals of Oncology, vol. 20(8) pp.1387-1396

Mercier C, Truntzer C, Pecqueur D, Gimeno JP, Belz G, Roy P (2009)
Mixed-model of ANOVA for measurement reproducibility in proteomics, Journal of Proteomics, vol. 72 pp.974-981

Descotes F, Riche B, Saez S, De Laroche G, Datchary J, Roy P, André P, Bobin J-Y (2008)
Plasminogen Activator Inhibitor Type 1 is the Most Significant of the Usual Tissue Prognostic Factors in Node-Negative Breast Ductal Adenocarcinoma Independent of Urokinase-Type Plasminogen Activator, Clinical Breast Cancer, vol. 8(2) pp.168-177

Le Scodan R, Mornex F, Partensky C, Mercier C, Valette P-J, Ychou M, Roy P, Scoazec J-Y (2008)
Histopathological Response to Preoperative Chemoradiation for Resectable Pancreatic Adenocarcinoma: the French phase IIFFCD 9704-SFRO trial, American Journal of Clinical Oncology-Cancer Clinical Trials, vol. 31(6) pp.545-552

Montoy M, Euvrard T, Moyen B, Roy P, Rollier J-C, Cotton F (2008)
Inter-observer agreement in the identiWcation of the two bundles of the anterior cruciate ligament using magnetic resonance imaging, Surgical and Radiologic Anatomy, vol. 30 pp.557-562

Tronchon V, Vialard F, El Sirkasi M, Dechaud H, Rollet J, Albert M, Bailly M, Roy P, Mauduit C, Fenichel P, Selva J, Benahmed M (2008)
Tumor necrosis factor-alpha 2308 polymorphism in infertile men with altered sperm production or motility, Human Reproduction, vol. 3(12) pp.2858-2866

Truntzer C, Maucort-Boulch D, Roy P (2008)
Comparative optimism in models involving both classical clinical and gene expression information, BMC Bioinformatics, vol. 9(434) pp.2762-2763

Kazkaz L, Marotte H, Hamwi M, Cazalis MA, Roy P, Mougin B (2007)
Rheumatoid arthritis and genetic markers in Syrian and French populations: different impact of the shared epitope, Annals of the Rheumatic Diseases, vol. 66 pp.195-201

Maucort-Boulch D, Djeridane M, Roy P, Riche B, Colonna P, Andrieu JM (2007)
Predictive and discriminating three-risk-group prognostic scoring system for staging Hodgkin lymphomas, Cancer, vol. 109 pp.256-264

Truntzer C, Mercier C, Estève J, Gautier C, Roy P (2007)
Importance of data structure in comparing two dimension reduction methods for classification of microarray gene expression data, BMC Bioinformatics, vol. 8 pp.1-12

Marotte H, Tournoud M, Cazalis MA, Mougin B, Roy P, Miossec P (2006)
Extensive multiallelic analysis of the relationship between HLA-DRB1 and rheumatoid arthritis using a Bayesian partition model, Genes and Immunity, vol. 7 pp.487-493

Maucort-Boulch D, Roy P (2006)
Modelling the effect of tamoxifen chemoprevention on long-term mortality in white women at high risk of breast cancer, European Journal of Cancer Prevention, vol. 15 pp.347-352

Mornex F, Girard N, Scoazec JY, Bossard N, Ychou M, Smith D, Seitz JF, Valette PJ, Roy P, Rouanet P, Ducreux M, Partensky C (2006)
Feasibility of pre-operative combined radiation therapy and chemotherapy with 5-fluorouracil and cisplatin in potentially resectable pancreatic adenocarcinoma: The French SFRO-FFCD 97-04 Phase II trial, International Journal of Radiation Oncology Biology Physics, vol. 65 pp.1471-1478

Perrot E, Guibert B, Mulsant P, Blandin S, Arnaud I, Roy P, Geriniere L, Souquet PJ (2005)
Preoperative chemotherapy does not increase complications in patients undergoing resection for non small cell lung cancer. Results of a retrospective study of 114 consecutive patients, The Annals of Thoracic Surgery, vol. 80 pp.423-427

Philippe S, Ducrot C, Roy P, Remontet L, Jarrige N, Calavas D (2005)
Sheep feed and scrapie France, Emerging Infectious Diseases, vol. 11 pp.1274-1279

Chaabane L, Pellet N, Bourdillon MC, Desbleds MC, Sulaiman A, Hadour G, Thivollet-Bejui F, Roy P, Briguet A, Douek P, Soulas EC (2004)
Contrast enhancement in atherosclerosis development in a mouse model: in vivo results at 2 Tesla. MAGMA, MAGMA, vol. 17 pp.188-195

Kodjikian L, Roy P, Rouberol F, Garweg JC, Chauvel P, Man`on L, Jean-Louis B, Little RE, Sasco AJ, Grange JD (2004)
Survival after proton-bean irradiation of uveal melanomas, American Journal of Ophthalmology, vol. 137 pp.1002-1010

Roman S, Cenni JC, Roy P, Pujol B, Napoleon B, Keriven-Souquet O, Souquet JC (2004)
Value of rectal ultrasound in predicting staging and outcome in patients with rectal adenocarcinoma, Diseases of the Colon and Rectum, vol. 47 pp.1323-1330

Rouberol F, Roy P, Kodjikian L, Gerard JP, Jean-Louis B, Grange JD (2004)
Survival anatomic and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years` experience with beta-rays), American Journal of Ophthalmology, vol. 137 pp.893-900

Solal-Celigny P, Roy P, Colombat P, White J, Armitage JO, Arranz-Saez R, Au WY, Bellei M, Brice P, Caballero D, Coiffier B, Conde-Garcia E, Doyen C, Federico M, Fisher RI, Garcia-Conde JF, Guglielmi C, Hageenbeek A , Haioun C , LeBlanc M , Lister AT, Lopez-Guillermo A, McLaughlin P, Milpied N , Morel P, Mounier N, Proctor SJ, Rohatiner A, Smith P, Soubeyran P , Tilly H, Vitolo U, Zinzani PL, Zucca E, Montserrat E (2004)
Follicular lymphoma international prognostic index, Blood, vol. 104 pp.1258-1265

Ducrot C, Roy P, Morignat E, Baron T, Calavas D (2003)
How the surveillance system may bias the results of analytical epidemiological studies on BSE: prevalence among dairy versus beef suckler cattle breeds in France, Veterinary Research, vol. 34 pp.185-192

Llorca G, Roy P, Riche B (2003)
Evaluation de résolution de problèmes mal définis en éthique clinique : variation des scores selon les méthodes de correction et les caractéristique des jurys, Pedagogie Médicale, vol. 4 pp.80-88

Zucca E, Conconi A , Mughal TI, Sarris AH , Seymour JF, Vitolo U, Klasa R, Ozsahin M, Mead GM, Gianni MA , Cortelazzo S, Ferreri A, Ambrosetti A, Martelli M, Thieblemont C, Moreno HG, Pinotti G, Martinelli G, Mozzana R, Grisanti S, Provencio M, Balzarotti M, Laveder F, Tean G, Callea V, Roy P, Cavalli F , Gospodarowicz MK (2003)
Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group, Journal of Clinical Oncology, vol. 21 pp.20-27

Chalabreysse L, Roy P, Cordier J-F, Loire R, Gamondes J-P, Thivolet-Bejui F (2002)
Correlation of the WHO Schema for the Classification of Thymic Epithelial Neoplasms With Prognosis, The American Journal of Surgical Pathology, vol. 26(12) pp.1605-1611

Lamy B, Roy P, Carret G, Flandrois J-P, Delignette-Muller M-L (2002)
What is the relevance of obtaining multiple blood samples for culture? A comprehensive model to optimize the strategy for diagnosing bacteremia, Clinical Infectious Diseases, vol. 35 pp.842-850

Mitry E, Benhamiche A-M, Couillault C, Roy P, Faivre-Finn C, Clinard F, Faivre J (2002)
Effect of age period of diagnosis and birth cohort on large bowel cancer incidence in a well-defined French population 1976-1995, European Journal of Cancer Prevention, vol. 11(6) pp.529-534

Thieblement C, Dumontet C, Saad H, Roch N, Bouafia F, Arnaud P, Hequet O, Espinouse D, Salles G, Roy P, Eljaafari-Corbin A, du Manoir-Baumgarten C, Coiffier B (2002)
Amifostine reduces mucosal damage after high-dose melphalan conditioning and autologous peripheral blood progenitor cell transplantation for patients with multiple myeloma, Bone Marrow Transplantation, vol. 30(11) pp.769-775

book :

Beuscart R, Bénichou J, Roy P, Quantin C (2009) Biostatistique, Omniscience, 2009